Episode 4: Can a Hedge Funder Cut Prescription Drug Costs?
(Bloomberg) -- Hedge-fund manager Kyle Bass has a plan that could cut the high cost of prescription drugs in the U.S. -- and make himself a lot of money. The strategy: Take short positions in a number of pharmaceutical companies while also trying to overturn their drug patents in court. Joining hosts Tracy Alloway and…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Odd Lots
See all episodes →Similar episodes from other shows
More like Odd Lots →
Can Trump Cut Prescription Prices?
Why are drug prices so high? Investigating the outdated US patent system | Priti Krishtel
The private credit boom
Are Price-Gouging Consumer Giants to Blame for High Inflation?
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.